Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Menlo Park, California
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 179 filings
- On EDGAR
- CIK 2070849
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 5
News 8 of 9
Prospectuses and Registrations 4
Proxies 2
Ownership 8 of 149
- SCHEDULE 13D/A Large holder reported an active stake, amended Nov 9, 2026
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
Other 8 of 10
- ARS Annual report sent to shareholders Apr 21, 2026
- CERT Exchange certified a listing Nov 5, 2025
- 8-A12B Registration of a security for exchange listing Nov 3, 2025
- DRSLTR Sep 17, 2025
- DRS/A Draft registration statement, submitted confidentially, amended Sep 17, 2025
- UPLOAD Comment letter from SEC staff Aug 26, 2025
- DRSLTR Aug 11, 2025
- DRS/A Draft registration statement, submitted confidentially, amended Aug 11, 2025
Everything here comes from BillionToOne, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.